Explore
Validate
LearnHPA019163
antibody from Atlas Antibodies
Targeting: CCL2
GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA019163 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA019163, RRID:AB_1846179
- Product name
- Anti-CCL2
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human CCL2, Gene description: chemokine (C-C motif) ligand 2, Alternative Gene Names: GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF, Validated applications: IHC, ICC, Uniprot ID: P13500, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references A Monoclonal Anti-HMGB1 Antibody Attenuates Neurodegeneration in an Experimental Animal Model of Glaucoma
MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in thecpkmodel of polycystic kidney disease
A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection
Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients
The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28–Costimulated T Cells Prepared for Adoptive Therapy
LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2‐induced STAT3 activation
Tonner H, Hunn S, Auler N, Schmelter C, Beutgen V, von Pein H, Pfeiffer N, Grus F
International Journal of Molecular Sciences 2022;23(8):4107
International Journal of Molecular Sciences 2022;23(8):4107
Toll-Like Receptor 3 as a Recurrence Risk Factor and a Potential Molecular Therapeutic Target in Colorectal Cancer
Yoshida T, Miura T, Matsumiya T, Yoshida H, Morohashi H, Sakamoto Y, Kurose A, Imaizumi T, Hakamada K
Clinical and Experimental Gastroenterology 2020;Volume 13
Clinical and Experimental Gastroenterology 2020;Volume 13
MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in thecpkmodel of polycystic kidney disease
Salah S, Meisenheimer J, Rao R, Peda J, Wallace D, Foster D, Li X, Li X, Zhou X, Vallejo J, Wacker M, Fields T, Swenson-Fields K
American Journal of Physiology-Renal Physiology 2019;317(2):F343-F360
American Journal of Physiology-Renal Physiology 2019;317(2):F343-F360
A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection
Månberg A, Bradley F, Qundos U, Guthrie B, Birse K, Noël-Romas L, Lindskog C, Bosire R, Kiarie J, Farquhar C, Burgener A, Nilsson P, Broliden K
Molecular & Cellular Proteomics 2019;18(3):461-476
Molecular & Cellular Proteomics 2019;18(3):461-476
Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients
Hamsten C, Wiklundh E, Grönlund H, Schwenk J, Uhlén M, Eklund A, Nilsson P, Grunewald J, Häggmark-Månberg A
Respiratory Research 2016;17(1)
Respiratory Research 2016;17(1)
The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28–Costimulated T Cells Prepared for Adoptive Therapy
Zsiros E, Duttagupta P, Dangaj D, Li H, Frank R, Garrabrant T, Hagemann I, Levine B, June C, Zhang L, Wang E, Marincola F, Bedognetti D, Powell D, Tanyi J, Feldman M, Kandalaft L, Coukos G
Clinical Cancer Research 2015;21(12):2840-2850
Clinical Cancer Research 2015;21(12):2840-2850
LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment
Peña C, Nakada Y, Saatcioglu H, Aloisio G, Cuevas I, Zhang S, Miller D, Lea J, Wong K, DeBerardinis R, Amelio A, Brekken R, Castrillon D
Journal of Clinical Investigation 2015;125(11):4063-4076
Journal of Clinical Investigation 2015;125(11):4063-4076
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2‐induced STAT3 activation
Izumi K, Fang L, Mizokami A, Namiki M, Li L, Lin W, Chang C
EMBO Molecular Medicine 2013;5(9):1383-1401
EMBO Molecular Medicine 2013;5(9):1383-1401
No comments: Submit comment
No validations: Submit validation data